spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

Smart Bioprocessing with the new Eppendorf Control System

Eppendorf

Flexible and intuitive operation of a wide range of biological processes with the SciVario® twin bioreactor control system.

Hamburg, February 12, 2020



Working with flexible systems that evolve with the changing needs in a lab is indispensable. With the SciVario twin, Eppendorf, a key life science company, introduces its latest bioreactor control system for small- and bench-scale applications. The intelligent controller and new, innovative bay-drawer system enables the exchange of standardized modules to flexibly adapt the controller to the changing requirements in a laboratory.

Smart bioprocessing – The innovative bioprocess controller is equipped with VisioNize® touch interface for easy connectivity to the VisioNize digital lab enabling remote monitoring of processes and custom notifications to users’ mobile devices.

Further intelligent recognition of connected devices and default-settings reduce the risk of operational errors. “All accessories are automatically identified and allow a switch from one to another vessel variant within less than 5 minutes,” states Dr. Patrick Priem, Principal Research Associate at GenMab, Netherlands.

For added flexibility, fourteen integrated TMFCs allow control of microbial and cell culture applications alike without the need to change any hardware components. Additional bioreactor vessel sizes up to 50 L and new functional modules are future introductions along with free intuitive software updates.

“We developed a future-proof bioprocess controller with innovative hardware & software concepts, empowered for future functionality extensions and an incorporation of the digital age.” says Dr. Karl Rix, Head of Business Unit Bioprocess at Eppendorf.
Smart user-interface and application flexibility enable the SciVario twin to fulfill the needs of new and experienced users in academia and industry. It is a premium modular bioprocess control station that will evolve together with users’ research and development needs.
For more information about the SciVario twin, please visit

Press Contact:
David Solbach
Eppendorf AG Bioprocess Center
Rudolf-Schulten-Str. 5
52428 Juelich, Germany 

Tel: +49 2461 980 168
Fax: +49 2461 980 100


About Eppendorf
Eppendorf is a leading life science company that develops and sells instruments, consumables and services for liquid handling, sample handling and cell handling in laboratories worldwide. Its product range includes pipettes and automated pipetting systems, dispensers, centrifuges, mixers, spectrometers and DNA amplification equipment as well as ultra-low temperature freezers, fermentors, bioreactors, CO2 incubators, shakers and cell systems. Consumables such as pipette tips, test tubes, microplates, and single-use bioreactor vessels complement the range of highest-quality premium products.

Eppendorf products are most broadly used in academic and commercial research laboratories, e.g., in companies from the pharmaceutical and biotechnological as well as the chemical and food industries. They are also aimed at clinical and environmental analysis laboratories, forensics and at industrial laboratories performing process analysis, production and quality assurance.

Eppendorf was founded in Hamburg, Germany in 1945 and has more than 3,300 employees worldwide. The company has subsidiaries in 26 countries and is represented in all other markets by distributors.
 
phone +49 2461 980 400
email bioprocess-info@eppendorf.de
web www.eppendorf.com
email Bioprocess Center Europe, Rudolf Schulten Str 5, 52428 Juelich
 
Print this page
Send to a friend
   
spacer
News and Press Releases

Safe’n’Spray: A Winner at CPhI Festival of Pharma

Nemera’s concept device Safe'n'SprayTM was rewarded under the category 'Excellence in Pharma - Drug Delivery Devices'
More info >>


White Papers

Financial implications of off-site visits in clinical research, perception versus reality

Illingworth Research

The concept of patient centricity is still relatively new within clinical trials. For too long, the most important person in the trial has been overlooked… the patient. Here, we explore the benefits of conducting a more patient-centric trial for the patient, site and sponsor through mobile, or ‘off-site’ visits. These advantages are much greater than purely financial, although the financial implications of running a more patient-focused clinical trial may previously have deterred some from this approach. Home nursing in clinical trials continues to be thought of as a high value “premium” service, which many sponsors decline in an attempt to remain within budget for the trial. However, is the actual cost of off-site nursing more expensive than the traditional site model?
More info >>

Industry Events

12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology

8-11 February 2021, Vienna, Austria

In continuation of the very successful scientific meetings in Budapest, Paris, Berlin, Florence, Geneva, Barcelona, Malta, Istanbul, Lisbon, Glasgow and Granada, the 12th PBP World will be held in Vienna from 8-11 Feb 2021. This every two year held conference has gained an ever increasing impact among the pharmaceutical scientists: With up to 1000 submitted abstracts and about 1300 participants it has become a well-established major meeting, attracting scientists from all over the world.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement